FOLH1 and sarcoidosis: Adding to the complexity of those potential false-positive or -negative discoveries, some of those pitfalls may apply to both imaging probes (e.g., sarcoidosis), but certain false findings may exist only for one of those PET agents (e.g., uptake in nervous tissue for PSMA-PET) [10, 11, 22, 23, 71].